Fever and granulocytopenia in children with acute lymphoblastic leukemia under induction therapy

Saudi Medical Journal

Volumn 22, Issue 5, 2001, Pages 423-427

  Meir, Hadir M ^a,b   Balawi, Ibrahim A ^a   Meer, Hala M ^a   Nayel, Hala ^a   Al Mobarak, Mohammad F ^a  

^a KING FAHAD GENERAL HOSPITAL   (Saudi Arabia)

^b King Abdulaziz Hosp and Oncology Centre   (Saudi Arabia)

Author keywords

Childhood acute lymphoblastic leukemia; Febrile neutropenia

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFTRIAXONE; CHLORAMPHENICOL DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN; TETRACYCLINE DERIVATIVE; TOBRAMYCIN; VANCOMYCIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; DISEASE SEVERITY; FEBRILE NEUTROPENIA; FEMALE; GRANULOCYTOPENIA; HUMAN; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; RESPIRATORY TRACT INFECTION; SAUDI ARABIA; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKOCYTE COUNT; MALE; MICROBIAL SENSITIVITY TESTS; NEUTROPENIA; NEUTROPHILS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0034984631     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Verhoef J. Prevention of infections in the neutropenic patient. Clin Infect Dis 1993; 17 Suppl 2: 359-367.
2. Wehl G, Allerberger F, Heitger A, Meister B, Maurer K, Fink FM. Trends in infection morbidity in a paediatric oncology ward. 1986-1995. Med Pediatr Oncol 1999; 32: 336-343.
3. Lennet EH, Balows A, Hausler WJJR, Shadony HJ. Manual of clinical microbiology. 1985; Washington DC.
4. Jansen J, Cromer M, Ahard L, Black JR, Wheat LJ, Allen SD. Infection prevention in severely myleosuppressed patients: A comparison between ciprofloxacin and regimen of selective antibiotic modulation of the intestinal flora. Am J Med 1994; 96: 335-341.
5. Petrilli AS, Dantas LS, Campus MC, Tanaka C, Glinani VC, Seker A. Oral Ciprofloxacin vs. Intravenous ceflriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: Randomized prospective trial. Med Pediatr Oncol 2000; 34: 87-91.
6. De Pauw BE, Deresinski SC, Feld R, Lane-Allman EF, Donnelly JP. Ceftazidine compared with piperacillin and tobramycin for the empiric treatment of fever in eutropenic patients with cancer. Amulticenter randomized trial. The intercontinental Antimicrobial Study Group. Ann Intern Med 1994; 120: 834-844.
7. Bow EJ, Koewen R and Vaughan D. Reduced requirement of antibiotic therapy targeting gram-negative organisms in febrile neutropenic patients with cancer who are receiving antibacterial chemoprophylaxis with oral quinolones. Clin Infect Dis 1995; 20: 907-912.
8. Funai N, Shimamoto Y, Tokunaga O, Sugihara W, Yamaguchi M. Ten-year survery of incidence of infection as a cause of death in hematologic malignancies: study of 90 autopsied cases. Acta-Haematol 1995; 93: 25-30.
9. Wheeler K, Chessells JM, Bailey CC, Richards SM. Treatment related deaths during induction and in first remissionin acute lymphblastic leukemia. Arch-Dis-Child 1996; 74: 101-107.
10. Jud B, Gmur J, Follath F. Type and frequency of severe infectious complications in the treatment of acute leukemia: Prospectively acquired findings in a consecutive patient cohort. Schweizmed-Wochenschr 1994; 124: 2060-2063.
11. Raje NS, Rao SR, Iyer RS, Kelkar RS, Pai SK, Nair CN et al. Infection analysis in acute lymphoblastic leukemia: a report of 499 consecutive episodes in India. Pediatr-Hematol-Oncol 1994; 11: 271-280.
12. Brodsky AL, Melero MJ, Minissale C, Sanchez-Avalos JC. Prognostic factors and mortality among adult patients with acute leukemia and infection. Medicina-B-Aires 1997; 57: 557-565.